4.850USD-2.51%Mkt Cap: 181.36M USDP/E: —Last update: 2026-06-01
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internati…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap181.36M USD
Enterprise Value366.86M USD
Revenue (TTM)129.46M USD
Gross Profit40.30M USD
Net Income (TTM)-38.72M USD
Revenue/Share3.464 USD
Last Price4.850 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees382
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.20
PEG2.66
EV/EBITDA44.51
EV/Revenue2.83
P/S1.45
P/B-13.25
EPS (TTM)-1.27
EPS (Forward)-0.81
52W Range
3.63023% of range8.980
52W High8.980 USD
52W Low3.630 USD
Profitability
Gross Margin31.27%
Oper. Margin-13.25%
EBITDA Margin6.37%
Profit Margin-30.04%
ROE272.62%
ROA-16.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-206.00K USD
CapEx (TTM)13.41M USD
FCF Margin—
FCF Yield—
Net Debt129.35M USD
Net Debt/EBITDA15.69
Balance Sheet
Debt/Equity-10.04
Current Ratio3.49
Quick Ratio2.18
Book Value/Sh-0.3790 USD
Cash/Share0.5540 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.667 USD
Target Range5.000 USD – 9.000 USD
# Analysts3
Ownership
Shares Out.37.51M
Float19.62M
Insiders2.28%
Institutions77.18%
Short Interest
Short Ratio12.1d
Short % Float8.41%
Short % Out.6.83%
Shares Short2.56M
Short (prev mo.)2.65M
Technical
SMA 504.631 (+4.7%)
SMA 2006.746 (-28.1%)
Beta1.08
S&P 52W Chg27.94%
Avg Vol (30d)189.27K
Avg Vol (10d)198.02K
Technical Indicators
RSI (14)54.8
MACD-0.0176
MACD Signal-0.0708
MACD Hist.+0.0532
BB Upper5.319 USD
BB Middle4.770 USD
BB Lower4.221 USD
BB Width23.01%
ATR (14)0.2719 USD
Vol Ratio (20d)0.43x